Kuros Biosciences Ag Stock Investor Sentiment

CSBTF Stock  USD 22.05  0.55  2.43%   
Roughly 61% of Kuros Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Kuros Biosciences AG pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Kuros Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Kuros Biosciences stock news signals to limit their universe of possible portfolio assets.
Kuros Biosciences pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Kuros daily returns and investor perception about the current price of Kuros Biosciences AG as well as its diversification or hedging effects on your existing portfolios.
  
over two months ago at news.google.com         
Medtronic spinal division inks agreement with Kuros Biosciences - Mass Device
Google News at Macroaxis
over two months ago at news.google.com         
Kuros Biosciences Locks 5-Year Exclusive Partnership with Medtronic for MagnetOs Spine Technology - ...
Google News at Macroaxis
over three months ago at news.google.com         
Kuros Biosciences Expands into 1B Extremities Market, Appoints New VP CSBTF Stock News - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
Kuros Biosciences AGs market cap dropped CHF107m last week Individual investors bore the brunt - Yah...
Google News at Macroaxis
over three months ago at news.google.com         
Kuros Biosciences AGs Shares Climb 30 percent But Its Business Is Yet to Catch Up - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Kuros Reports 149 percent Increase in Direct MagnetOs Sales and Exceeds Cash Flow Breakeven in the F...
Google News at Macroaxis
over three months ago at news.google.com         
Investing in Kuros Biosciences a year ago would have delivered you a 786 percent gain - Yahoo Financ...
Google News at Macroaxis
over three months ago at news.google.com         
Kuros Biosciences rallies 9.4 percent this week, taking one-year gains to 805 percent - Simply Wall ...
Google News at Macroaxis
over three months ago at news.google.com         
Kuros Biosciences rallies 9.4 percent this week, taking one-year gains to 805 percent - Simply Wall ...
Google News at Macroaxis
over six months ago at news.google.com         
Market Participants Recognise Kuros Biosciences AGs Revenues Pushing Shares 37 percent Higher - Simp...
Google News at Macroaxis
over six months ago at news.google.com         
Kuros Biosciences Reports First Half of 2024 Results - StockTitan
Google News at Macroaxis
over six months ago at news.google.com         
We Think Kuros Biosciences Can Afford To Drive Business Growth - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Retail investors invested in Kuros Biosciences AG up 13 percent last week, insiders too were rewarde...
Google News at Macroaxis
over six months ago at news.google.com         
Kuros Biosciences AG Stocks Shoot Up 28 percent But Its PS Still Looks Reasonable - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Kuros Biosciences hikes 13 percent this week, taking one-year gains to 431 percent - Simply Wall St
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Kuros Biosciences that are available to investors today. That information is available publicly through Kuros media outlets and privately through word of mouth or via Kuros internal channels. However, regardless of the origin, that massive amount of Kuros data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kuros Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kuros Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kuros Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kuros Biosciences alpha.

Kuros Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Kuros Pink Sheet analysis

When running Kuros Biosciences' price analysis, check to measure Kuros Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kuros Biosciences is operating at the current time. Most of Kuros Biosciences' value examination focuses on studying past and present price action to predict the probability of Kuros Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kuros Biosciences' price. Additionally, you may evaluate how the addition of Kuros Biosciences to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum